Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2002 2
2003 3
2005 3
2006 2
2007 2
2008 1
2010 1
2011 2
2012 2
2013 6
2014 1
2015 4
2016 1
2017 1
2018 4
2019 3
2020 7
2021 5
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of HCC with claudin-1-specific antibodies suppresses carcinogenic signaling and reprograms the tumor microenvironment.
Roehlen N, Muller M, Nehme Z, Crouchet E, Jühling F, Del Zompo F, Cherradi S, Duong FHT, Almeida N, Saviano A, Fernández-Vaquero M, Riedl T, El Saghire H, Durand SC, Ponsolles C, Oudot MA, Martin R, Brignon N, Felli E, Pessaux P, Lallement A, Davidson I, Bandiera S, Thumann C, Marchand P, Moll S, Nicolay B, Bardeesy N, Hoshida Y, Heikenwälder M, Iacone R, Toso A, Meyer M, Elson G, Schweighoffer T, Teixeira G, Zeisel MB, Laquerriere P, Lupberger J, Schuster C, Mailly L, Baumert TF. Roehlen N, et al. Among authors: lupberger j. J Hepatol. 2023 Feb;78(2):343-355. doi: 10.1016/j.jhep.2022.10.011. Epub 2022 Oct 27. J Hepatol. 2023. PMID: 36309131 Free article.
A monoclonal antibody targeting nonjunctional claudin-1 inhibits fibrosis in patient-derived models by modulating cell plasticity.
Roehlen N, Saviano A, El Saghire H, Crouchet E, Nehme Z, Del Zompo F, Jühling F, Oudot MA, Durand SC, Duong FHT, Cherradi S, Gonzalez Motos V, Almeida N, Ponsolles C, Heydmann L, Ostyn T, Lallement A, Pessaux P, Felli E, Cavalli A, Sgrignani J, Thumann C, Koutsopoulos O, Fuchs BC, Hoshida Y, Hofmann M, Vyberg M, Viuff BM, Galsgaard ED, Elson G, Toso A, Meyer M, Iacone R, Schweighoffer T, Teixeira G, Moll S, De Vito C, Roskams T, Davidson I, Heide D, Heikenwälder M, Zeisel MB, Lupberger J, Mailly L, Schuster C, Baumert TF. Roehlen N, et al. Among authors: lupberger j. Sci Transl Med. 2022 Dec 21;14(676):eabj4221. doi: 10.1126/scitranslmed.abj4221. Epub 2022 Dec 21. Sci Transl Med. 2022. PMID: 36542691
Oncogenic Signaling Induced by HCV Infection.
Virzì A, Roca Suarez AA, Baumert TF, Lupberger J. Virzì A, et al. Among authors: lupberger j. Viruses. 2018 Oct 2;10(10):538. doi: 10.3390/v10100538. Viruses. 2018. PMID: 30279347 Free PMC article. Review.
Stromal and Immune Drivers of Hepatocarcinogenesis.
Saviano A, Roehlen N, Virzì A, Roca Suarez AA, Hoshida Y, Lupberger J, Baumert TF. Saviano A, et al. Among authors: lupberger j. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 15. 2019 Aug 6. In: Hoshida Y, editor. Hepatocellular Carcinoma: Translational Precision Medicine Approaches [Internet]. Cham (CH): Humana Press; 2019. Chapter 15. PMID: 32078263 Free Books & Documents. Review.
Viral manipulation of STAT3: Evade, exploit, and injure.
Roca Suarez AA, Van Renne N, Baumert TF, Lupberger J. Roca Suarez AA, et al. Among authors: lupberger j. PLoS Pathog. 2018 Mar 15;14(3):e1006839. doi: 10.1371/journal.ppat.1006839. eCollection 2018 Mar. PLoS Pathog. 2018. PMID: 29543893 Free PMC article. Review.
Nucleic Acid-Induced Signaling in Chronic Viral Liver Disease.
Roca Suarez AA, Testoni B, Baumert TF, Lupberger J. Roca Suarez AA, et al. Among authors: lupberger j. Front Immunol. 2021 Feb 5;11:624034. doi: 10.3389/fimmu.2020.624034. eCollection 2020. Front Immunol. 2021. PMID: 33613561 Free PMC article. Review.
Memories of Stress: The Imprinted Cancer Risk After HCV Cure.
Lupberger J, Baumert TF. Lupberger J, et al. Cell Mol Gastroenterol Hepatol. 2023;16(2):323-324. doi: 10.1016/j.jcmgh.2023.05.006. Epub 2023 Jun 2. Cell Mol Gastroenterol Hepatol. 2023. PMID: 37271182 Free PMC article. No abstract available.
Claudins and pathogenesis of viral infection.
Tawar RG, Colpitts CC, Lupberger J, El-Saghire H, Zeisel MB, Baumert TF. Tawar RG, et al. Among authors: lupberger j. Semin Cell Dev Biol. 2015 Jun;42:39-46. doi: 10.1016/j.semcdb.2015.04.011. Epub 2015 May 7. Semin Cell Dev Biol. 2015. PMID: 25960372 Review.
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Crouchet E, Bandiera S, Fujiwara N, Li S, El Saghire H, Fernández-Vaquero M, Riedl T, Sun X, Hirschfield H, Jühling F, Zhu S, Roehlen N, Ponsolles C, Heydmann L, Saviano A, Qian T, Venkatesh A, Lupberger J, Verrier ER, Sojoodi M, Oudot MA, Duong FHT, Masia R, Wei L, Thumann C, Durand SC, González-Motos V, Heide D, Hetzer J, Nakagawa S, Ono A, Song WM, Higashi T, Sanchez R, Kim RS, Bian CB, Kiani K, Croonenborghs T, Subramanian A, Chung RT, Straub BK, Schuppan D, Ankavay M, Cocquerel L, Schaeffer E, Goossens N, Koh AP, Mahajan M, Nair VD, Gunasekaran G, Schwartz ME, Bardeesy N, Shalek AK, Rozenblatt-Rosen O, Regev A, Felli E, Pessaux P, Tanabe KK, Heikenwälder M, Schuster C, Pochet N, Zeisel MB, Fuchs BC, Hoshida Y, Baumert TF. Crouchet E, et al. Among authors: lupberger j. Nat Commun. 2021 Sep 17;12(1):5525. doi: 10.1038/s41467-021-25468-9. Nat Commun. 2021. PMID: 34535664 Free PMC article.
56 results